|Articles|January 18, 2021
Supplements and Featured Publications
- COPD Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes
Chronic Obstructive Pulmonary Disease Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes
Advertisement
This activity is supported by an educational grant from Boehringer Ingelheim.
This AJMC® Stakeholder Summit provides a multistakeholder perspective on current treatment options, recent guideline recommendations, and approaches for health care decision makers and clinicians for the individualized management of chronic obstructive pulmonary disease (COPD).
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
5